These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 19380021)

  • 1. Genetic alterations detected by comparative genomic hybridization and recurrence rate in epithelial ovarian carcinoma.
    Bruchim I; Israeli O; Mahmud SM; Aviram-Goldring A; Rienstein S; Friedman E; Ben-Baruch G; Gotlieb WH
    Cancer Genet Cytogenet; 2009 Apr; 190(2):66-70. PubMed ID: 19380021
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High-resolution genomic profiling of carboplatin resistance in early-stage epithelial ovarian carcinoma.
    Osterberg L; Levan K; Partheen K; Staaf J; Sundfeldt K; Horvath G
    Cytogenet Genome Res; 2009; 125(1):8-18. PubMed ID: 19617691
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparative genomic hybridization detects genetic imbalances in primary ovarian carcinomas as correlated with grade of differentiation.
    Kiechle M; Jacobsen A; Schwarz-Boeger U; Hedderich J; Pfisterer J; Arnold N
    Cancer; 2001 Feb; 91(3):534-40. PubMed ID: 11169935
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Phyllodes tumors of the breast analyzed by comparative genomic hybridization and association of increased 1q copy number with stromal overgrowth and recurrence.
    Lu YJ; Birdsall S; Osin P; Gusterson B; Shipley J
    Genes Chromosomes Cancer; 1997 Nov; 20(3):275-81. PubMed ID: 9365835
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genetic changes in inherited and sporadic ovarian carcinomas by comparative genomic hybridization: extensive similarity except for a difference at chromosome 2q24-q32.
    Tapper J; Sarantaus L; Vahteristo P; Nevanlinna H; Hemmer S; Seppälä M; Knuutila S; Butzow R
    Cancer Res; 1998 Jul; 58(13):2715-9. PubMed ID: 9661879
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chromosomal losses of regions on 5q and lack of high-level amplifications at 8q24 are associated with favorable prognosis for ovarian serous carcinoma.
    Staebler A; Karberg B; Behm J; Kuhlmann P; Neubert U; Schmidt H; Korsching E; Bürger H; Lelle R; Kiesel L; Böcker W; Shih IeM; Buchweitz O
    Genes Chromosomes Cancer; 2006 Oct; 45(10):905-17. PubMed ID: 16845658
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genetic alterations related to lymph node metastasis and peritoneal dissemination in epithelial ovarian cancers.
    Umayahara K; Numa F; Inokuma A; Sueoka K; Kawasaki K; Hirakawa H; Emoto T; Sakaguchi Y; Nawata S; Ogata H; Sakamoto M; Hasumi K; Kawauchi S; Sasaki K; Kato H
    Oncol Rep; 2002; 9(5):1115-9. PubMed ID: 12168082
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Mechanisms of drug resistance in human ovarian carcinoma studied by comparative genomic hybridization].
    Ying HC; Zhang SL; Jiang T; Ouyang L; Lü J
    Zhonghua Yi Xue Za Zhi; 2007 Apr; 87(15):1009-12. PubMed ID: 17672960
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Can bladder adenocarcinomas be distinguished from schistosomiasis-associated bladder cancers by using array comparative genomic hybridization analysis?
    Vauhkonen H; Böhling T; Eissa S; Shoman S; Knuutila S
    Cancer Genet Cytogenet; 2007 Sep; 177(2):153-7. PubMed ID: 17854674
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Array-comparative genomic hybridization analysis of primary endometrial and ovarian high-grade neuroendocrine carcinoma associated with adenocarcinoma: mystery resolved?
    Mhawech-Fauceglia P; Odunsi K; Dim D; Nowak N; Lele S; Cheney RT; Pejovic T
    Int J Gynecol Pathol; 2008 Oct; 27(4):539-46. PubMed ID: 18753966
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A copy number gain of the 6p arm is linked with advanced hepatocellular carcinoma: an array-based comparative genomic hybridization study.
    Chochi Y; Kawauchi S; Nakao M; Furuya T; Hashimoto K; Oga A; Oka M; Sasaki K
    J Pathol; 2009 Apr; 217(5):677-84. PubMed ID: 19097070
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genetic alterations of serous borderline tumors of the ovary compared to stage I serous ovarian carcinomas.
    Osterberg L; Akeson M; Levan K; Partheen K; Zetterqvist BM; Brännström M; Horvath G
    Cancer Genet Cytogenet; 2006 Jun; 167(2):103-8. PubMed ID: 16737908
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genetic signatures of HPV-related and unrelated oropharyngeal carcinoma and their prognostic implications.
    Klussmann JP; Mooren JJ; Lehnen M; Claessen SM; Stenner M; Huebbers CU; Weissenborn SJ; Wedemeyer I; Preuss SF; Straetmans JM; Manni JJ; Hopman AH; Speel EJ
    Clin Cancer Res; 2009 Mar; 15(5):1779-86. PubMed ID: 19223504
    [TBL] [Abstract][Full Text] [Related]  

  • 14. DNA profiling of primary serous ovarian and fallopian tube carcinomas with array comparative genomic hybridization and multiplex ligation-dependent probe amplification.
    Nowee ME; Snijders AM; Rockx DA; de Wit RM; Kosma VM; Hämäläinen K; Schouten JP; Verheijen RH; van Diest PJ; Albertson DG; Dorsman JC
    J Pathol; 2007 Sep; 213(1):46-55. PubMed ID: 17668415
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gene expression meta-analysis identifies chromosomal regions involved in ovarian cancer survival.
    Thomassen M; Jochumsen KM; Mogensen O; Tan Q; Kruse TA
    Genes Chromosomes Cancer; 2009 Aug; 48(8):711-24. PubMed ID: 19441089
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular evidence for progression of microglandular adenosis (MGA) to invasive carcinoma.
    Shin SJ; Simpson PT; Da Silva L; Jayanthan J; Reid L; Lakhani SR; Rosen PP
    Am J Surg Pathol; 2009 Apr; 33(4):496-504. PubMed ID: 19047897
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ovarian pathology in risk-reducing salpingo-oophorectomies from women with BRCA mutations, emphasizing the differential diagnosis of occult primary and metastatic carcinoma.
    Rabban JT; Barnes M; Chen LM; Powell CB; Crawford B; Zaloudek CJ
    Am J Surg Pathol; 2009 Aug; 33(8):1125-36. PubMed ID: 19440148
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparative genome hybridization reveals specific genomic imbalances during the genesis from benign through borderline to malignant ovarian tumors.
    Helou K; Padilla-Nash H; Wangsa D; Karlsson E; Osterberg L; Karlsson P; Ried T; Knutsen T
    Cancer Genet Cytogenet; 2006 Oct; 170(1):1-8. PubMed ID: 16965948
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gene expression profiles of luteal phase fallopian tube epithelium from BRCA mutation carriers resemble high-grade serous carcinoma.
    Tone AA; Begley H; Sharma M; Murphy J; Rosen B; Brown TJ; Shaw PA
    Clin Cancer Res; 2008 Jul; 14(13):4067-78. PubMed ID: 18593983
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genomic analyses of primary and metastatic serous epithelial ovarian cancer.
    Israeli O; Gotlieb WH; Friedman E; Korach J; Friedman E; Goldman B; Zeltzer A; Ben-Baruch G; Rienstein S; Aviram-Goldring A
    Cancer Genet Cytogenet; 2004 Oct; 154(1):16-21. PubMed ID: 15381367
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.